Pancreatic Cancer Research

ResearcherHospital of the University of PennsylvaniaNo recent work listed

Ronac Mamtani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8267-5356; OpenAlex author ID A5055266545. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 9

  1. Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival. Co-author DOI 10.1001/jamanetworkopen.2023.45013↗
  2. A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes. Co-author DOI 10.1097/meg.0000000000002052↗
  3. Digoxin use is associated with pancreatic cancer risk but does not affect survival. Co-author DOI 10.1007/s10552-020-01352-7↗
  4. Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations. Co-author DOI 10.1093/jncics/pkaa121↗
  5. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study. Co-author DOI 10.1002/pds.4993↗
  6. Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1200/jop.19.00328↗
  7. Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study. Co-author DOI 10.1158/1055-9965.epi-18-0421↗
  8. Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation. Co-author DOI 10.1200/po.18.00271↗
  9. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. Co-author DOI 10.1053/j.gastro.2016.11.046↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ben Boursi · 7 shared papers, 2017–2023 · strength 0.95
  2. Kim A. Reiss · 5 shared papers, 2019–2023 · strength 0.66
  3. Yu‐Xiao Yang · 5 shared papers, 2017–2022 · strength 0.64
  4. Susan M. Domchek · 3 shared papers, 2019–2023 · strength 0.46
  5. Talia Golan · 2 shared papers, 2020–2023 · strength 0.30
  6. Shun Yu · 2 shared papers, 2019–2021 · strength 0.26
  7. Andrew D. Rhim · 2 shared papers, 2017–2022 · strength 0.24
  8. Zain M. Hannan · 1 shared paper, 2021 · strength 0.17
  9. William Chang-Yuen Chen · 1 shared paper, 2019 · strength 0.14
  10. Erin Mary Bange · 1 shared paper, 2020 · strength 0.11
  11. Jeffrey D. Goldstein · 1 shared paper, 2020 · strength 0.09
  12. Akram Saad · 1 shared paper, 2020 · strength 0.09
  13. Yaacov Richard Lawrence · 1 shared paper, 2020 · strength 0.09
  14. Peter James O'Dwyer · 1 shared paper, 2019 · strength 0.09
  15. Parul Agarwal · 1 shared paper, 2019 · strength 0.09
  16. Katherine L. Nathanson · 1 shared paper, 2019 · strength 0.09
  17. Mark H. O’Hara · 1 shared paper, 2019 · strength 0.09
  18. Anil K. Rustgi · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.